Literature DB >> 19719431

Effect of radiation on vascular endothelial growth factor expression in the C2 canine mastocytoma cell line.

Ivana Sekis1, Wilhelm Gerner, Michael Willmann, Laura Rebuzzi, Alexander Tichy, Martina Patzl, Johann G Thalhammer, Armin Saalmüller, Miriam M Kleiter.   

Abstract

OBJECTIVE: To establish the radiosensitivity and effect of irradiation on vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) expression in the canine mastocytoma cell line C2. SAMPLE POPULATION: Canine mastocytoma cell line C2. PROCEDURES: C2 cells were irradiated with single doses of 2, 4, 6, and 8 Gy. The 3-(4, 5-di-methyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide assay and proliferation assays with (methyl-hydrogen 3) thymidine were used for radiosensitivity experiments. Expression of VEGFR was determined via flow cytometry and apoptotic rate via annexin assay. Human and canine VEGF ELISA kits were evaluated in crossover assay experiments, and the canine kit was used thereafter.
RESULTS: C2 cells secreted VEGF constitutively. Radiation did not induce a significant increase in VEGF secretion, regardless of radiation dose. Consistently, radiation did not up-regulate VEGFR. Cell survival rates decreased in a dose-dependent manner. The apoptotic cell fraction had a dose-dependent increase that reached its maximum 24 to 48 hours after radiation. CONCLUSIONS AND CLINICAL RELEVANCE: The C2 cell line was radiosensitive, and a fraction (up to 40%) of cells died via apoptosis in a dose-dependent manner. In response to radiation, C2 cells did not upregulate VEGF production or VEGFR. Further studies are needed to determine whether tumor control could be improved by combining radiotherapy with VEGFR inhibitors or apoptosis-modulating agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719431     DOI: 10.2460/ajvr.70.9.1141

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  5 in total

1.  Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer.

Authors:  Jing-Ping Yu; Su-Ping Sun; Zhi-Qiang Sun; Xin-Chu Ni; Jian Wang; Yi Li; Li-Jun Hu; Dong-Qing Li
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

2.  Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.

Authors:  Fernanda B Mantovani; Jodi A Morrison; Anthony J Mutsaers
Journal:  BMC Vet Res       Date:  2016-05-31       Impact factor: 2.741

3.  Pilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours.

Authors:  Lucas Da Silva; Carlos E Fonseca-Alves; Jennifer J Thompson; Robert A Foster; Geoffrey A Wood; Renee L Amorim; Brenda L Coomber
Journal:  Vet Med Sci       Date:  2017-06-30

4.  Radiation up-regulates the expression of VEGF in a canine oral melanoma cell line.

Authors:  Irene Flickinger; Barbara C Rütgen; Wilhelm Gerner; Ivana Calice; Alexander Tichy; Armin Saalmüller; Miriam Kleiter
Journal:  J Vet Sci       Date:  2013-06-21       Impact factor: 1.672

5.  Proteomics identification of radiation-induced changes of membrane proteins in the rat model of arteriovenous malformation in pursuit of targets for brain AVM molecular therapy.

Authors:  Margaret Simonian; Dyna Shirasaki; Vivienne S Lee; David Bervini; Michael Grace; Rachel R Ogorzalek Loo; Joseph A Loo; Mark P Molloy; Marcus A Stoodley
Journal:  Clin Proteomics       Date:  2018-12-26       Impact factor: 3.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.